Stock 503 LANSEN PHARMACEUTICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Lansen Pharmaceutical Holdings Limited

Equities

503

KYG5380M1033

Pharmaceuticals

Business Summary

Lansen Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Specialty Pharmaceuticals segment is engaged in the development, production and sales of specialty pharmaceuticals mainly used in the fields of rheumatology and dermatology. Its main specialty pharmaceutical products include pafulin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant Extract and Healthcare Products segment is engaged in the development, production and sales of Chinese medicine extracts and healthcare products. Other Pharmaceuticals segment is engaged in businesses related to other pharmaceuticals.

Number of employees: 652

Managers

Managers TitleAgeSince
Li Chen CEO
 Chief Executive Officer 62 01/18/01
Kai Fai Pang SEC
 Corporate Secretary - 13/19/13
Yu Zhao HRO
 Human Resources Officer 51 11/15/11

Members of the board

Members of the board TitleAgeSince
Ching Har Chan BRD
 Director/Board Member 67 10/22/10
Zhen Tao Wu CHM
 Chairman 70 30/17/30
Kee Huen Chan BRD
 Director/Board Member 72 09/10/09
Xun Zhu BRD
 Director/Board Member 66 23/22/23
Xue Zi Liu BRD
 Director/Board Member 47 30/16/30
Li Chen CEO
 Chief Executive Officer 62 01/18/01
Tak Bun Yeung BRD
 Director/Board Member 58 06/18/06

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 419,328,434 133,103,274 ( 31.74 %) 0 31.74 %

Company contact information

Lansen Pharmaceutical Holdings Ltd.

228 Xinfeng Road Gaoqiao Industrial Park

315174, Ningbo

+

http://www.lansen.com.cn
address Lansen Pharmaceutical Holdings Limited(503)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 503 Stock
  4. Company Lansen Pharmaceutical Holdings Limited